Enter: the GLP-1 support patch
Safety Management Considerations: Gastrointestinal side effects predominate, but are generally manageable via dose titration
Soriano, P., Montgomery, C., Geske, R
When in doubt, reach out to your healthcare team
Earlier animal studies with malnourished mothers reported that delayed ossification is associated with decreased maternal body weight, and maternal malnutrition or reduced intake are common pathways to decreased fetal weight/growth and ossification (6669), but malnutrition models did not report the increase in major congenital anomalies reported after gestational exposure to GLP-1 agonists
Users often report noticeable improvements in skin radiance, reduction in dark spots, and overall complexion enhancement within weeks of consistent supplementation